Detalhe da pesquisa
1.
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38587079
2.
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.
Lancet HIV
; 6(10): e667-e679, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31473167